End points for predicting coronary risk must be clarified

BMJ. 2001 Aug 18;323(7309):396-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Anticholesteremic Agents / therapeutic use
  • Coronary Disease / prevention & control*
  • Disease-Free Survival
  • Humans
  • Male
  • Middle Aged
  • Risk

Substances

  • Anticholesteremic Agents